CD274 and head and neck squamous cell carcinoma: This is due to the different scoring systems available for PD-L1, such as the tumor proportion score (TPS), the immune cell (IC) score, and the combined positive score (CPS) [4], the latter being recommended in the HNSCC setting [5].